New hope for Tough-to-Treat bile duct cancer?
NCT ID NCT03044587
Summary
This study tested if a new combination of chemotherapy drugs (nal-IRI with 5-FU) could better control advanced bile duct cancer compared to a standard treatment. It involved 93 adults whose cancer could not be removed by surgery. The main goal was to see if the new combination could slow the cancer's growth for a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
Conditions
Explore the condition pages connected to this study.